Gnai3-KO Mouse
一般名
Gnai3-KO
製品ID
S-KO-19469
背景情報
C57BL/6JCya
系統ID
KOCMP-14679-Gnai3-B6J-VC
状況
このマウス系統を論文で使用する場合は、「Gnai3-KO Mouse(カタログ番号S-KO-19469)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Gnai3-KO
系統ID
KOCMP-14679-Gnai3-B6J-VC
遺伝子名
製品ID
S-KO-19469
遺伝子別名
Hg1a, Gnai-3, Galphai3
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 3
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000000001
NCBIトランスクリプトID
NM_010306
ターゲット領域
Exon 2~3
有効領域の大きさ
~1.9 kb
遺伝子研究の概要
Gnai3, also known as Guanine nucleotide binding protein, alpha inhibiting activity polypeptide 3, is involved in multiple biological processes. It participates in signaling pathways, such as those related to cytokine regulation and G-protein-coupled receptor signaling, and is of great biological importance in processes like cell migration, inflammation, and tumorigenesis [4,2,1]. Genetic models, like Gnai3-iresGFP reporter mice, are useful tools for studying its expression patterns [3].
In mice, GNAI1 and GNAI3 double-knockout (DKO) mice showed more severe colitis and significantly more colonic tumors compared to control mice after treatment with dextran sulfate sodium (DSS) and azoxymethane (AOM). The increased tumor development was associated with activation of NF-κB and STAT3, increased levels of GNAI2, nitric oxide synthase 2, and IL6, and changes in immune cell populations. Blocking IL6 with an antibody reduced the expansion of myeloid-derived suppressor cells (MDSCs) and the number of tumors in DKO mice, indicating that GNAI3 suppresses DSS-plus-AOM-induced colon tumor development by blocking IL6 signaling and down-regulating GNAI2 expression [1]. In hepatocellular carcinoma (HCC) cells, GNAI3 inhibits cell migration and invasion, and its down-regulation, potentially caused by up-regulation of miR-222, promotes HCC cell migration and invasion [4]. In non-alcoholic fatty liver disease (NAFLD) models, GNAI3 knockout enhanced dysregulated hepatic lipid metabolism and liver damage in mice, and down-regulation of GNAI3 promoted cellular lipid accumulation in HepG2 cells, suggesting GNAI3 is involved in NAFLD development [5].
In conclusion, Gnai3 plays crucial roles in various biological processes and disease conditions. The use of gene knockout mouse models, such as in colitis-associated tumorigenesis and NAFLD studies, has revealed its functions in inhibiting tumor development and regulating lipid metabolism. Its down-regulation in certain cancers like HCC is associated with increased cell migration and invasion. Understanding Gnai3's functions provides insights into disease mechanisms and potential therapeutic targets.
References:
1. Li, Zhi-Wei, Sun, Beicheng, Gong, Ting, Zhou, Xiqiao, Chu, Wen-Ming. 2019. GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2. In Gastroenterology, 156, 2297-2312. doi:10.1053/j.gastro.2019.02.040. https://pubmed.ncbi.nlm.nih.gov/30836096/
2. Guo, Ling, Sun, Hua, Pu, Jiao. 2024. GNAI3 mediated by Lin28A regulates lipopolysaccharide-induced inflammation and osteogenic differentiation in periodontal stem cells by mediating the NF-κB/NLRP3 inflammasome pathway. In Archives of oral biology, 163, 105974. doi:10.1016/j.archoralbio.2024.105974. https://pubmed.ncbi.nlm.nih.gov/38636252/
3. Leiss, Veronika, Reisinger, Ellen, Speidel, Annika, Beer-Hammer, Sandra, Nürnberg, Bernd. 2021. Analyses of Gnai3-iresGFP reporter mice reveal unknown Gαi3 expression sites. In Scientific reports, 11, 14271. doi:10.1038/s41598-021-93591-0. https://pubmed.ncbi.nlm.nih.gov/34253772/
4. Zhang, Yu, Yao, Jian, Huan, Lin, Liang, Linhui, He, Xianghuo. 2014. GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma. In Cancer letters, 356, 978-84. doi:10.1016/j.canlet.2014.11.013. https://pubmed.ncbi.nlm.nih.gov/25444921/
5. Zhu, Hanzhang, Ge, Ke, Lu, Jun, Jia, Changku. . Downregulation of GNAI3 Promotes the Pathogenesis of Methionine/Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease. In Gut and liver, 14, 492-499. doi:10.5009/gnl19115. https://pubmed.ncbi.nlm.nih.gov/31694365/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
